Drug Trial Radar · NCT07292025
Phase 1 Trial of JTM201 in Subjects With Post-stroke Upper Limb Spasticity
Last checked: Nov 19, 2026Latest source record: Dec 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Actual
Start
Jun 29, 2023
Primary completion
Apr 22, 2024
Study completion Sep 4, 2024
Sponsor
- Lead sponsor
- Jetema Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Dec 18, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Phase 1 trial to evaluate the safety and efficacy of JTM201 compared with 'Botox® Inj.' in subjects with post-stroke upper limb spasticity
Conditions
- Upper Limb Spasticity Post-Stroke
Interventions
JTM201 in normal salineDrug
Max 360 U of Test drug IM
BOTOX 100U in normal salineDrug
Max 360 U of BOTOX IM
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in Modified Ashworth Scale score of Wrist FlexorTime frame: Week 4, Week 8, Week 12
- Change from baseline in Modified Ashworth Scale score of Elbow Flexor, Finger FlexorTime frame: Week 4, Week 8, Week 12
- Proportion of subjects with at least 1-point improvement from baseline in the Modified Ashworth Scale score for the Wrist Flexor, Elbow Flexor, Finger FlexorTime frame: Week 4, Week 8, Week 12
- Changes from baseline in Disability Assessment Scale scoreTime frame: Week 4, Week 8, Week 12
- Global Assessment Scale evaluated by investigatorTime frame: Week 4, Week 8, Week 12
- Global Assessment Scale evaluated by patientsTime frame: Visit 3, 4, 5
- Change from baseline in Caregiver Burden Scale completed by caregiverTime frame: Week 4, Week 8, Week 12
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Seoul Boramae Hospital
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.